Validity of clinical criteria for the diagnosis of dementia with Lewy bodies

Neurology

Volumn 53, Issue 9, 1999, Pages 1974-1982

  Verghese, J ^a   Crystal, H A ^a   Dickson, D W ^b   Lipton, R B ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c Innovative Medical Research   (United States)

Author keywords

AD; Clinical criteria; Dementia with Lewy bodies

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC VALUE; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; LEWY BODY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; VALIDATION PROCESS;

EID: 0032762636     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.9.1974     Document Type: Article

References (34)

1. Rogers SL, Farlow MR, Doody RS, et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease: donepezil study group. Neurology 1998; 50:136-145.
2. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegeline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-1222.
3. Davis KL, Powchik P. Tacrine. Lancet 1995;345:625-630.
4. Lebert F, Souliez L, Pasquier F. Tacrine and symptomatic treatment in SDLT. In: Perry R, McKeith I, Perry E, eds. Lewy body dementia. New York: Cambridge University Press, 1997:439-448.
5. Levy R, Eagger S, Griffiths M, et al. Lewy bodies and response to tacrine in Alzheimer's disease. Lancet 1994;343:176. Letter.
6. McKeith IG, Fairbairn A, Perry R, et al. Neuroleptic sensitivity in patients with senile dementia of the Lewy body type. BMJ 1992;305:673-678.
7. Olichney JM, Galasko D, Salmon DP, et al. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 1998;51:351-357.
8. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
9. Mega MS, Masterman DL, Benson F, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathological criteria. Neurology 1996;47:1403-1409.
10. Ala TA, Yang K-H, Sung JH, et al. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1997;62:16-21.
11. Litvan I, Agid Y, Goetz CG, et al. Accuracy of the clinical diagnosis of non-Alzheimer dementias. Neurobiol Aging 1998; 19(suppl 2):S173. Abstract.
12. McShane RH, Esiri MM, Joachim C, et al. Prospective evaluation of diagnostic criteria for dementia with Lewy bodies. Neurobiol Aging 1998;19(suppl 2):S204. Abstract.
13. Olin JT, Zarow C, Fox LS, et al. Difficulty in identifying a clinical syndrome due to Lewy bodies. Neurobiol Aging 1998; 19(suppl 2):S204. Abstract.
14. Perry R, Jaro E, Ince P, et al. Dementia with Lewy bodies: diagnostic accuracy using consensus criteria. Neurobiol Aging 1998;19(suppl 2):S203. Abstract.
15. Blessed G, Tomlinson E, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811.
16. Crystal H, Dickson D, Fuld P, et al. Clinico-pathological studies in dementia: non-demented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988;38:1682-1687.
17. Crystal H, Dickson, DW, Lizardi J, et al. Ante mortem diagnosis of diffuse Lewy body disease. Neurology 1990;40:1523-1528.
18. Lang AE, Fahn S. Assessment of Parkinson's disease. In: Mustat TL, ed. Quantification of neurologic deficit. London: Butterworth, 1989:285-309.
19. McDowell I, Newel C. The theoretical and technical foundations of health measurement. In: McDowell I, Newel C, eds. Measuring health: a guide to rating scales and questionnaires. New York: Oxford University Press, 1996:10-46.
20. Gifford DR, Cummings JL. Evaluating dementia screening tests: methodologic standards to rate their performance. Neurology 1999;52:224-227.
21. Crook R, Hardy J, Duff K. One day APOE genotyping. J Neurosci Methods 1994;53:125-127.
22. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997; 56:1095-1097.
23. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
24. Dickson DW, Crystal HA, Mattiace LA. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992;13:179-189.
25. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990;237:197-204.
26. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA group under the auspices of Department of HHS Task force on Alzheimer's disease. Neurology 1984;34:939-944.
27. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990;40:1-8.
28. Perry RH, Irving D, Blessed G, et al. Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-139.
29. Skoog I, Nilsson L, Palmertz B, et al. A population based study of dementia in 85-year olds. N Engl J Med 1993;328: 153-158.
30. Hansen LA. Pathology of other dementias. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer disease. New York: Raven Press, 1994:167-178.
31. Crystal HA, RB Lipton, P Davies, et al. Dementia of unknown etiology is not early Alzheimer's disease. Neurology 1999; 52(suppl 2):A562. Abstract.
32. Crystal HA, RB Lipton, D Dickson. Non-Alzheimer dementia in the very elderly is frequent and often associated with hippocampal sclerosis. Neurology 1998;50(suppl 4):A60. Abstract.
33. McKeith IG, Perry RH, Fairbairn AF, et al. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
34. McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy bodies international workshop. Neurology 1999;53:902-905.